May 16, 2024, 05:00 AM by User Not Found

Bio-IT World | The lab of W. Andy Tao, professor of biochemistry at Purdue University, is pioneering a way to assess drug response based on metabolizing proteins found in circulating extracellular vesicles (EVs), which could serve as a surrogate of their expression level in the liver and become therapeutic targets for some cancers.

May 15, 2024, 08:31 AM by

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

May 15, 2024, 08:31 AM by

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

May 15, 2024, 08:31 AM by

May 15, 2024, 08:31 AM by

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

May 15, 2024, 08:31 AM by

Kalderos Names Healthcare Industry Veteran Daryl Todd as Chief Strategy Officer

May 15, 2024, 08:31 AM by

InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs

May 15, 2024, 08:31 AM by

PLUTO’s embeddings will enable prediction of underlying molecular alterations driving cancer and disease phenotypes–including those previously hidden to AI–as well as the discovery of new biomarkers and therapeutic targets.

May 15, 2024, 08:31 AM by

May 15, 2024, 08:31 AM by

Optibrium’s AI-powered discovery platform Cerella™ chosen by FMC to accelerate its agrochemical discovery pipeline

May 15, 2024, 05:00 AM by User Not Found

Bio-IT World | Significant evidence now exists implicating the Epstein-Barr virus (EBV) as a causal factor in the development of multiple sclerosis (MS), making treatment of the virus a priority. To that end, research scientists at Trinity College Dublin have developed a blood test to measure the immune response to EBV that could be used as an outcome measure in future clinical trials in people with established MS.

May 14, 2024, 07:27 AM by

https://www.prnewswire.com/news-releases/fdb-expands-its-medication-instructions-to-include-translations-of-hindi--punjabi-2-of-the-fastest-growing-languages-in-the-us-302141989.html?tc=eml_cleartime

May 14, 2024, 07:27 AM by

Switchboard Health, creator of a high-value specialty care network and software platform, has secured $6.5 million in series seed funding.

May 14, 2024, 07:27 AM by

May 14, 2024, 07:27 AM by

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). The company also reduced its standard turnaround time on WES and WGS to three weeks and continues to provide rapid testing with written reports in as few as five days.

May 14, 2024, 07:27 AM by

May 14, 2024, 07:27 AM by

Watson-Marlow Fluid Technology Solutions (WMFTS) will showcase its recently launched DriveSure® panel mount pumps along with other products for life sciences companies at ACHEMA 2024 in Germany (June 10-14).

May 14, 2024, 07:27 AM by

Built on the strong visions and values of the Trust, Guy’s and St Thomas’ “Together We Care” strategy centers on three primary priorities, Patients, People, and Partnerships, aiming to bolster patient autonomy, invest in staff, and harness technologies in collaboration with commercial partners. Guy’s and St Thomas’ implementation of PhenoTips’ Genomic Health Record on the final year of their 2018-2023 strategy completes the ambitious 5-year plan by empowering patients to take an active role in the collection of their data, streamlining staff and provider workflows, and establishing a framework for deep integration between the partner technologies supporting the Trust.

May 14, 2024, 05:00 AM by User Not Found

Bio-IT World | Using an artificial intelligence (AI) model that was trained on millions of variants from identified genetic disorders and incorporates the complex decision-making process of human molecular scientists, investigators at Baylor College of Medicine are on track to automate the diagnosis of an enormous number of undiagnosed conditions.

May 13, 2024, 08:37 AM by

The biotech startup Lactocore Group has reported unusual properties of a proprietary peptide, LCGA-17m16, aimed at treating neurological disorders without harming the heart that signal a potential paradigm shift in treating neurological disorders.